TEYLA

QUALITATIVE AND QUANTITATIVE COMPOSITION

Teyla contains etonogestrelum 11 mg and ethinylestradiolum 3,474 mg. The ring releases etonogestrel and ethinylestradiol at an average amount of 0,120 mg a ethinylestradiolum 0,015 mg respectively per 24 hours, over a period of 3 weeks.

PHARMACEUTICAL FORM

Vaginal delivery system.

Teyla is flexible, transparent, and colourless to almost colourless ring, with an outer diameter of 54 mm and a cross-sectional diameter of 4 mm.

DISPENSING AND REIMBURSEMENT

Medicinal product is subjected to medical prescription. The medicinal product is not covered by public health insurance.